Abstract: Nanoparticle platforms are being intensively investigated for neurological applications. Current biological models used to identify clinically relevant materials have major limitations, e.g. technical/ethical issues with live animal experimentation, failure to replicate neural cell diversity, limited control over cellular stoichiometries and poor reproducibility. High-throughput neuro-mimetic screening systems are required to address these challenges. We describe an advanced multicellular neural model comprising the major non-neuronal/glial cells of the central nervous system (CNS), shown to account for ~99.5% of CNS nanoparticle uptake. This model offers critical advantages for neuro-nanomaterials testing whilst reducing animal use: one primary source and culture medium for all cell types, standardized biomolecular corona formation and defined/reproducible cellular stoichiometry.
Introduction
Advanced functional material design has led to a global increase in clinical nanomaterial use for regenerative medicine, particularly platforms such as magnetic particles (MPs), in applications including imaging and biomolecule delivery, with several therapeutic nanoparticles under clinical trials or in pre-clinical development. 1, 2 Identification and optimization of such medical biomaterials requires dedicated design and realization of surface functionalization with appropriate materials characterization tools, and parallel biomedical testing using relevant biomimetic screening models. Neurological applications represent a unique challenge in this regard, given the complex, multicellular composition of the brain and spinal cord (termed the central nervous system or CNS). 3 Neural cells are classed into neurons (transmitters of electrical information) or glia (the supporting cells). Glia outnumber neurons by about 10-fold [4] [5] [6] [7] and comprise several subtypes that regulate the neural environment including, critically, clearance of nanomaterials. 8 One study recently proved that glial uptake of nanoparticles accounts for ca. 99.5% of nanoparticle clearance in the CNS, with neurons accounting for the small balance 9 -identifying the former as the overwhelmingly dominant population governing CNS nanoparticle uptake. Consequently, the overall response of the glial population to introduced nanomaterials is the most critical predictor of the CNS characteristic response as a whole.
We recently reported major differences in MP uptake/handling between glia. 10 The immune components (microglia) showed rapid and avid particle uptake with extensive degradation. In contrast, other glial subtypes (the astrocytes, oligodendrocytes and their precursors) showed significantly lower but stable particle accumulation. Based on these observations, we predicted that the rapid and high particle accumulation by a dominant cell population, such as microglia, would constitute a critical 'extracellular barrier' to particle uptake in mixed neural 4 cell populations, such as the intact nervous system. This is pertinent as high numbers of activated microglia are typically present in neurological pathology. 11 Accordingly, the development and testing of neuro-compatible materials for clinical use must account for both intercellular dynamics and constituent glial cell numbers, using appropriate multicellular neural models.
Despite this major need there is a substantial lack of sophisticated and accessible neural models for high-throughput screening of neuro-nanomaterials. 12 In terms of widely used current approaches, live animal models are biologically relevant but involve significant ethical issues, technical complexity and expense, whilst being low-throughput. 16 and reducing their predictive utility.
Another major point of note is that biomolecule interactions with materials at the nanoscalethe same length scale as proteins -underpin the affinity between the surface and the biomolecule upon adsorption. In biological media, with ~30,000 different proteins likely present at varying abundance, 17 there is competition for adsorption sites on nanoparticles.
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The so-called 'protein corona' formed around nanoparticles is highly dependent on their 5 characteristics (surface chemical functionality and nano-topography). [19] [20] [21] Most studies investigate cell-material interactions in isolated, purified mono-cultures, propagated in cellspecific media wherein differentially modified materials are presented to cells, even when the same defined starting nanoparticles are used. 10 This would substantially impact the readouts of intercellular comparisons of materials' handling (as the cells encounter this corona rather than the material surface). 19 Given this important confounding variable, it is important that the same biological medium be used with all cell types under study, to standardize experiments and elucidate true cellular responses to nanomaterials. This is especially relevant for neural cells, which co-exist in the same extracellular fluid in the intact nervous system, but with individual subtypes typically requiring biochemically distinctive media for survival and propagation in vitro.
To address these challenges, we developed a multi-glial cell screening model for nanomaterials with the following key features: (i) a standardized culture medium developed in-house for the model, which permits survival of all cell types; (ii) derivation of all cells from a single primary source; (iii) reproducible experimenter control over cellular stoichiometry; (iv) ease of nanomaterial delivery and (v) compatibility with a range of analytical/microscopic techniques. To evaluate the biological utility of the new model in predicting neural responses to introduced materials, we have challenged the system with well-characterized MPs, to test the hypothesis that a 'microglial barrier' exists, limiting particle uptake by other neural subtypes (a phenomenon previously only inferred from postmortem observations following nanoparticle introduction into the intact CNS).
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Materials and Methods
The care and use of animals was in accordance with the Animals (Scientific Procedures) Act of 1986 (United Kingdom) with approval by the local ethics committee.
Materials
Tissue culture-grade plastics, media, and media supplements were from Fisher Scientific 10 and detection of Sphero-labelled cells using MRI illustrates their biological utility. 23 MPs were incubated in media (3 h; 20 µg mL -1 ), magnetically separated, washed and air dried onto aluminium discs. FTIR data was collected on a Bruker Alpha system using a DRIFT attachment, with 512 scans being averaged at a resolution of 4 cm -1 . Amide I band component peak fitting was performed using previously defined parameters, 24 and an in-house program built using Omnic Macros Basic (Thermofisher Scientific). Eigen Vector Solo was used for PCA analysis, with all data being mean centered. The hydrodynamic diameter and zeta-potential of Sphero particles in cellular media were determined using a Zetasizer Nano ZS (Malvern, UK). All media contain carbonate buffer to maintain a pH of ~7.4 while incubated (37 °C, 5% CO2/95% humidified air). As pH can influence particle-media interactions, cell culture conditions were replicated: 7 media were incubated for 24 h prior to particle addition (50 µg mL -1 ) with the 5% CO2
headspace being sealed between removal and measurement. Measurements were made at 37 °C, 5 min and 24 h following particle addition. Table S1 ).
Development
Development of the standardized 'gliosupportive' medium
All cells were plated on PDL coated 24 well plates (astrocytes at 4 x 10 4 cells cm -2 ; microglia at 9 x 10 4 cells cm -2
; OPCs at 6 x 10 4 cells cm -2 ). In pilot experiments, mono-cultures of each cell type were tested for 48 h in various cell specific media (Supplementary Table S2 ). To develop a gliosupportive medium, D10 medium supplemented with conditioned D10 medium 8 from parent mixed glial cultures was tested (D10-CM; conditioned medium derived 48 h after last medium change, sterile-filtered and stored at 4 °C).
Competitive uptake studies
To test our proposed 'extracellular barrier' hypothesis using our multicellular model, Sphero particles (20 µg mL -1 ) were added to glial mono-cultures or 50:50 co-cultures, 24 h after plating in the gliosupportive medium. Mono-cultures served as internal controls, demonstrating intrinsic particle uptake by each cell type. After 24 h, all cultures were washed and fixed (4% paraformaldehyde) for immunocytochemistry. 
Immunocytochemistry
Fluorescence microscopy for toxicity and uptake analyses
Samples were photographed on an Axio Scope A1 fluorescence microscope (Carl Zeiss MicroImaging, Germany) and images merged using Photoshop CS3. A minimum of three microscopic fields and 100 nuclei per culture were assessed for all conditions. Toxicity was assessed by morphological observations and by comparing proportions of pyknotic nuclei (pyknotic/ healthy plus pyknotic), identified as small, intensely stained and often fragmenting. Culture purity and stoichiometry were determined by assessing the percentage of cells expressing cell-specific markers. Extent of MP-loading was assessed using a semiquantitative technique by comparison with the average cross-sectional area of an OPC, as described previously. 10 Briefly, uptake was scored as low (<10% of the area of an average nucleus), medium (10 -50%) or high (>50%). Elsewhere, we have discussed the benefits of this technique versus techniques deriving an average value for fluorescence or iron per cell. 10 9
Further, measurements of 'intracellular' iron content (using colorimetric absorbance assays) include substantial proportions of extracellular (membrane-bound) particles: 20% of the iron per cell value for microglia, 27 and up to 50% for astrocytes. 28 Such techniques also assume an even distribution between cells and we have shown that considerable heterogeneity exists within glial subtypes in terms of extent of uptake.
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Statistical analysis
Data were analyzed using Prism software (GraphPad, CA, USA) and are expressed as mean ± standard error of the mean unless stated otherwise. 'n' refers to the number of primary cultures from which mixed glial fractions were derived, each established from a different 
Live cell dynamic time-lapse imaging
To study microglial behavior (specifically membrane activity and survival), mono-cultures were plated in PDL-coated 24 well plates (6 x 10 4 cells cm -2 , D10). After 24 h, cultures were imaged using time-lapse phase contrast microscopy (Nikon Eclipse Ti fluorescence microscope with Nikon DS-U2/L2 camera and NIS Elements BR 3.22.14 software), then Sphero MPs were added (20 µg mL -1 ) and cultures imaged using time-lapse microscopy. To assess if microglial behavior was similar in mono versus co-cultures, a mixed glial culture was subjected to time-lapse imaging before and after Sphero addition (20 µg mL -1 , D10-CM).
In separate experiments, cells were fixed and stained for transmission electron microscopy This was confirmed in further pilot experiments, in which astrocytes, microglia and OPCs were added to an oligodendrocyte culture (at 8 DIV) and all four cell types could be successfully co-cultured in D10-CM for 48 h.
Microglia dramatically reduce MP uptake by other cell types proving the 'extracellular barrier' hypothesis in our model
For all cell types, the particle dose used here has previously been tested in monocultures, without evidence of toxicity at 24 h. 10, 23, 30 To rule out Sphero-induced toxicity in multicellular cultures, cell viability assays were conducted. No toxicity was observed in mono-or co-cultures: no differences in cellular adherence or cellular/nuclear morphology 13 were apparent by phase/fluorescence microscopy following immunostaining. No significant differences in numbers of pyknotic nuclei were found between mono-and co-cultures (less than 5% of cells, consistent with our previous reports). 10, 23, 30 Glial Notably, no MP-loading was apparent in astrocytes or OPCs in mixed cultures over the same period. Some microglia extended processes over and around neighboring cells, a behavior that may be expected to limit the latter cells' access to particles.
Discussion
Here, we have successfully developed a multicellular (multi-glial) model for the developmental testing of medical biomaterials. Representation of all the major glial subtypes in the model ensures mimicry of the in vivo situation where the glia account for ca. 99.5% of nanoparticle uptake from the extracellular environment. 9 We utilized our approach to demonstrate for the first time, the existence of a competitive 'microglial barrier' to particle uptake in other neural cells in real-time. Parallel derivation of all glial types for the model from a single primary source, as achieved here, avoids problems with cell lines which are often of unknown provenance (origin and treatment history) 31 and altered physiology, 32 potentially leading to dramatically different nanoparticle uptake dynamics and toxicity profiles compared with primary cells. 16 Our method also ensures that constituent cells possess identical ages/anatomical origins, with culture under identical conditions. Further, by achieving defined cellular stoichiometry with high reproducibility, direct intercellular comparisons can be reliably drawn. The even cellular distribution in monolayers facilitated light and fluorescence microscopical analysis, obviating the need for confocal or z-stack identification of labelled cells. This system was also analyzed using time-lapse light and fluorescence microscopy, highlighting the potential to provide dynamic detail about particle uptake and particle-induced changes in cellular behavior (e.g. altered motility). As such, we consider that our model offers significant advantages over alternative neural co-culture systems currently used within the nanomedicine community.
As far as we are aware, we are also the first to demonstrate that different biomolecular coronas are formed in different neural media, identifying this as a critical confounding variable in cross-cellular comparisons of materials handling. Competitive protein binding to interfaces is a highly dynamic process, with distinct variability in the composition of the formed biolayer in different biochemical media. 19, 21, 33, 34 Changes in the protein corona presented at the particle surface lead to variance in how cells 'perceive' particles, through non-specific interaction or specific receptor mediated responses. Therefore, the cell-material interactions can be expected to vary between media. Secondary structure changes within the protein corona are indicative of a global change within the adsorbed protein layer. 18, 35 Here we clearly highlight this variability. Differences in global secondary structure were observed from component amide I band fitting, particularly with respect to the α-helical component.
PCA analysis of spectra further supported this finding, with discrimination between coronas formed from the four different media being highly resolved depending upon secondary structure component bands. Consequently, development of a single medium to support all cell types was a major outcome, to overcome issues associated with medium-specific corona formation. Therefore, we consider this model can provide a true reflection of multiple glial responses to nanomaterials, as pertains in complex neural tissue. Further analysis of the protein corona in future studies would allow for a more detailed insight into the mechanisms underpinning particle-neural cell interactions, where a major knowledge gap currently exists.
Techniques such as 2D PAGE and mass spectrometry can be used to characterize the protein components of the corona, for various particle-medium combinations. This may reveal correlations between the presence of particular proteins and specific cell-particle interactions in those media; the predictive value of such data would greatly aid particle design for optimized cell interaction and internalization.
Astrocytes and OPCs showed dramatic reductions in MP uptake upon culture with microglia, confirming that extensive and avid microglial uptake is a major extracellular all of which will limit particle uptake by other neural cells in the vicinity.
We consider that the versatility of the model allows for diverse screening applications in regenerative neurology. For example, biomaterials intended to evade microglial clearance and/or target specific neural cell types could be tested, and the effects of drugs on competitive uptake dynamics could be assessed. There is also considerable scope to increase the 18 sophistication of the model in terms of cellular complexity (including addition of neurons) and tailored stoichiometry (Figure 6 ). Consequently, this facile system can be employed to conduct head-to-head comparisons of biomaterials handling by glial cells, and provides a foundation by which screening approaches can be standardized. We predict that such neuromimetic models have the potential to accelerate the rate of discovery of neurocompatible and efficacious materials for neuroregenerative applications, whilst taking a major step towards reducing live animal experimentation. 
